Published May 21, 2013
Volume 21, Number 5

  • PowerbyProxi, a developer and supplier of wireless power solutions, has joined the Wireless Power Consortium (WPC) as part of the group’s management team. The WPC sets the global “Qi” (pronounced “chee”) standard for wireless electrical power transfer over distances of up to 1.6 inches via electromagnetic induction. PowerbyProxi will contribute to the WPC by extending specifications to address applications for smartphones, as well as higher power tablets, PC ultrabooks and notebooks, and high power kitchen appliances, while ensuring backward compatibility with the existing Qi ecosystem.

    “The WPC has built a significant worldwide market based on the Qi specification and continues to gain momentum,” said Greg Cross, Executive Chairman of PowerbyProxi. “Becoming a full member, and participating in the management team, enables us to leverage our proven expertise by making contributions that will deliver solutions for a better user experience while expanding to a wider range of consumer devices and appliances,” said Cross.

    PowerbyProxi also recently closed a $5 million Series C funding round.
  • Hacienda’s CooperVision has launched a Science and Technology (S&T) Awards Program. The program will address eye health through advancement of technologies including materials, devices and compounds. The program consists of two separate awards. The CooperVision Seedling Award is intended to incentivize collaborations with CooperVision in a new research area for a one year period, and carries a maximum award of $100,000. The CooperVision Translational Research Award is a multi-year award for a substantive translational research project and may total up to $400,000 over two years or $250,000 over one year.

    “Our goal is to support science and encourage a focus on unmet needs that can be translated back to our community," said Arthur Back , Chief Technology Officer for CooperVision. “I am pleased that the CooperVision S&T Awards will provide scientists in academia and research institutes a substantive opportunity to pursue emerging ideas and concepts in a meaningful and focused way.”
  • Hacienda’s NeoTract reports that a 206-patient study of men with benign prostatic hyperplasia (BPH), an enlargement of the prostate gland, has determined that the company’s UroLift System treatment provides rapid symptomatic improvement, increased urinary flow rates, and preserved sexual function, among other benefits.“The successful completion of the rigorous L.I.F.T. study marks a significant milestone for the UroLift System and NeoTract highlighting the potential this minimally invasive treatment option brings to patients suffering from an enlarged prostate," said Dave Amerson , President and CEO, NeoTract. Inc. "Given its strong therapeutic benefit and safety profile, we believe UroLift will be a first line treatment option for patients with BPH."

Also in this issue ...